Hygea VCT plc


Overview
Hygea VCT was launched in 2001 as BioScience VCT to invest in bioscience companies, with a particular focuis on investing in treatment development companies. Since then, the Board has shifted emphasis to investing in medical technology companies (eg devices, drug delivery systems, diagnostics etc). The investment strategy is to seek companies with the potential to conform to certain key criteria including; an industry relevant team, competitive value to customers, scalability in global markets and a recurring business revenue model. Comapnies in which the VCT has invested to date include; Immunodiagnostics plc, Epistem Holdings plc, Omega Diagnostics Group plc, Prosurgics Ltd, Hallmarq Veterinary Imaging, Scancell plc, DxS and BioAnaLab Ltd.


Historic Prices
No auction history

Auctions
Next auction date Indicative price Highest bid (p) Lowest offer (p) Market type Auction frequency Next auction time
30 Sep 10 n/a 58.00 n/a Open Monthly 5:00pm

Announcements
Title Date
Director's Dealings 06 Aug 10
Share Trading - End of Close Period 05 Aug 10
Share Trading - Start of Close Period 01 Jul 10

Report & accounts
Title Date
Interim Accounts to June 10 05 Aug 10
Report and Accounts to December 2009 31 Mar 10
Interim Accounts to June 09 09 Nov 09

Fundamentals
Year ending Sales (£m) Pre-tax profit (£m)
31 Dec 2008 N/A 0.4180

Directors
Name
James Otter (Chairman)
John Hustler
Charles Breese

Website
www.hygeavct.com

Sitemap